Microfocused Ultrasound in Regenerative Aesthetics: A Narrative Review on Mechanisms of Action and Clinical Outcomes
- PMID: 39501429
- PMCID: PMC11847762
- DOI: 10.1111/jocd.16658
Microfocused Ultrasound in Regenerative Aesthetics: A Narrative Review on Mechanisms of Action and Clinical Outcomes
Abstract
Background: Microfocused ultrasound with visualization (MFU-V) is widely used in aesthetic medicine for skin tightening and rejuvenation. However, its role in regenerative aesthetics and its precise mechanism of action are not fully understood.
Objective: This narrative review aims to contextualize and articulate the mechanism of action of MFU-V, evaluate its role in regenerative aesthetics, and assess its effectiveness based on existing clinical, histological, and skin-mechanical studies.
Methods: A comprehensive literature search was performed to collect and analyze studies on MFU's biological mechanisms, clinical outcomes, and impact on extracellular matrix (ECM) regeneration. The review integrates findings from clinical trials, histological analyses, and biomechanical assessments to provide a cohesive understanding of MFU-V's role in aesthetic medicine.
Results: MFU-V emits focused ultrasound energy that penetrates multiple skin layers and the superficial musculoaponeurotic system, creating localized thermal coagulation points. These points initiate biological responses that recruit fibroblasts and stimulate the production of new collagen and elastin fibers. Enhanced ECM protein synthesis leads to significant improvements in skin biomechanics and quality, reducing skin laxity and enhancing appearance. Clinical studies support these findings, showing improvements in skin firmness and texture following MFU-V treatment.
Conclusion: Through analyzing the underlying biological mechanisms and the observable clinical outcomes, this narrative review sets the stage for a comprehensive understanding of the mechanism of action and role of MFU-V in regenerative aesthetics.
Keywords: MFU‐V; Ultherapy; energy‐based devices; microfocused ultrasound with visualization; regenerative aesthetics.
© 2024 The Author(s). Journal of Cosmetic Dermatology published by Wiley Periodicals LLC.
Conflict of interest statement
Drs. Akers, Jackson, and McCarthy are employed by Merz Aesthetics (Raleigh, NC).
Dr. Vachiramon is a consultant and speaker for Merz Aesthetics, Beiersdorf, and L’Oreal. Dr. Pavicic is a consultant and speaker for Merz Aesthetics and Advanced Aesthetic Technologies, and an investigator for Merz Aesthetics, AbbVie, AAT, LG, and Croma. Dr. Casabona consults for Merz Aesthetics. Dr. Green speaks, advises, and conducts clinical trials for Allergan Aesthetics, Croma‐Pharma GmbH, Crown Pharmaceuticals, Inc., Cutera, Galderma, L’Oreal USA, Merz Aesthetics, Revance Therapeutics, Inc., Revelle Aesthetics, Silk Medical Aesthetics, Inc., and SkinBetter Science. Dr. Levine consults and speaks for Allergan and BTL, advises Galderma and Merz Aesthetics, and speaks for RVL. Dr. Park consults for Merz Pharmaceuticals, Allergan, and LG Chem. Dr. Spada is a consultant and speaker for Merz Aesthetics. Dr. Muniz is a medical consultant and speaker for Merz Aesthetics. Drs. Akers, Jackson, and McCarthy are employees of Merz Aesthetics.
Figures
References
-
- Goldie K., “The Evolving Field of Regenerative Aesthetics,” Journal of Cosmetic Dermatology 22 (2023): 1–7. - PubMed
-
- Zarbafian M., Fabi S. G., Dayan S., and Goldie K., “The Emerging Field of Regenerative Aesthetics—Where We Are Now,” Dermatologic Surgery 48 (2022): 101–108. - PubMed
-
- Chernoff G., “The Utilization of Human Placental Mesenchymal Stem Cell Derived Exosomes in Aging Skin: An Investigational Pilot Study,” Journal of Surgery 6, no. 5 (2021): 1–10, 10.29011/2575-9760.001388. - DOI
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
